Inventor · disambiguated record
Sandy Fabre
Also filed as: FABRE SANDY
3 granted patents·3 pending applications·5 citations·filing 2013–2022
60Inventor score
Files withAELIS FARMA2INST NAT SANTE RECH MED2INSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)1INSERM LNSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE1
Top patents by PatentIndex Score
6 records- 0177US11484537B23β-(4-methoxybenzyloxy)pregn-5-en-20-one for use in the treatment of cannabinoids-related disordersAELIS FARMA·Filed 2019·Granted Nov 1, 2022·2 cites·19 claims
- 0275US10259839B23-(4′-substituted)-benzyl-ether derivatives of pregnenoloneINST NAT SANTE RECH MED·Filed 2013·Granted Apr 16, 2019·3 cites·4 claims
- 0363US12447159B23β-(4-methoxybenzyloxy)pregn-5-en-20-one for use in the treatment of Cannabinoids-Related DisordersAELIS FARMA·Filed 2022·Granted Oct 21, 2025·0 cites·24 claims
- 0461US2021230211A13-(4'-substituted)-benzyl-ether derivatives of pregnenoloneINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 0553US2019202857A13-(4'-substituted)-benzyl-ether derivatives of pregnenoloneINSERM LNSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE·Filed 2019·Application pending·0 cites
- 0650US2017226148A13-(4'-substituted)-benzyl-ether derivatives of pregnenoloneINSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sandy Fabre files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →